Literature DB >> 11692162

Phenotypic dichotomy in mitochondrial complex II genetic disorders.

B E Baysal1, W S Rubinstein, P E Taschner.   

Abstract

This review presents our current knowledge on the genetic and phenotypic aspects of mitochondrial complex II gene defects. The mutations of the complex II subunits cause two strikingly different group of disorders, revealing a phenotypic dichotomy. Genetic disorders of the mitochondrial respiratory chain are often characterized by hypotonia, growth retardation, cardiomyopathy, myopathy, neuropathy, organ failure, and metabolic derangement. These disorders are transmitted through maternal lineage if the defective gene is located in the mitochondrial genome or may follow a Mendelian pattern if it is in the nucleus. Mitochondrial complex II (succinate:ubiquinone oxidoreductase) is the smallest complex in the respiratory chain and is composed of four subunits encoded by nuclear genes SDHA, SDHB, SDHC, and SDHD. Complex II oxidizes succinate to fumarate in the Krebs cycle and is involved in the mitochondrial electron transport chain. SDHA and SDHB encode the flavoprotein and iron-sulfur proteins, respectively, and SDHC and SDHD encode the two hydrophobic membrane-spanning subunits. While mutations in SDHA display a phenotype resembling other mitochondrial and Krebs cycle gene defects, those in SDHB, SDHC and SDHD cause hereditary paraganglioma. Paraganglioma is characterized by slow-growing vascular tumors of the paraganglionic tissue (i.e., adrenal and extra-adrenal paragangliomas, including those in the head and neck, mediastinum, abdomen, and pheochromocytomas). Paraganglioma caused by SDHD mutations occurs exclusively after paternal transmission, suggesting that genomic imprinting influences gene expression. Association of a mitochondrial gene defect with tumorigenesis expands the phenotypic spectrum of mitochondrial diseases and adds genomic imprinting as a new transmission mode in mitochondrial genetics. The phenotypic features of complex II gene mutations suggest that whereas the catalytic subunit SDHA mutations may compromise the Krebs cycle, those in other structural subunits may affect oxygen sensing and signaling.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11692162     DOI: 10.1007/s001090100267

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


  13 in total

Review 1.  Physiological consequences of complex II inhibition for aging, disease, and the mKATP channel.

Authors:  Andrew P Wojtovich; C Owen Smith; Cole M Haynes; Keith W Nehrke; Paul S Brookes
Journal:  Biochim Biophys Acta       Date:  2013-01-02

Review 2.  Mutations of the SDHB and SDHD genes.

Authors:  Christian Pawlu; Birke Bausch; Hartmut P H Neumann
Journal:  Fam Cancer       Date:  2005       Impact factor: 2.375

Review 3.  Hereditary paraganglioma targets diverse paraganglia.

Authors:  B E Baysal
Journal:  J Med Genet       Date:  2002-09       Impact factor: 6.318

Review 4.  Molecular genetic alterations in adrenal and extra-adrenal pheochromocytomas and paragangliomas.

Authors:  Hilde Dannenberg; Paul Komminoth; Winand N M Dinjens; Ernst Jan M Speel; Ronald R de Krijger
Journal:  Endocr Pathol       Date:  2003       Impact factor: 3.943

5.  Atpenins, potent and specific inhibitors of mitochondrial complex II (succinate-ubiquinone oxidoreductase).

Authors:  Hiroko Miyadera; Kazuro Shiomi; Hideaki Ui; Yuichi Yamaguchi; Rokuro Masuma; Hiroshi Tomoda; Hideto Miyoshi; Arihiro Osanai; Kiyoshi Kita; Satoshi Omura
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-06       Impact factor: 11.205

Review 6.  [Paraganglioma in the area of the head and neck. A review of molecular genetic research].

Authors:  S Braun; K Riemann; C M Pusch; K Sotlar; M Pfister; S Kupka
Journal:  HNO       Date:  2004-01       Impact factor: 1.284

7.  Autosomal dominant malignant and catecholamine-producing paraganglioma caused by a splice donor site mutation in SDHC.

Authors:  Stephan Niemann; Ulrich Müller; Dieter Engelhardt; Peter Lohse
Journal:  Hum Genet       Date:  2003-03-25       Impact factor: 4.132

8.  Progressive cerebellar atrophy in a patient with complex II and III deficiency and a novel deleterious variant in SDHA: A Counseling Conundrum.

Authors:  Beattie R H Sturrock; Ellen F Macnamara; Peter McGuire; Shannon Kruk; Ivan Yang; Jennifer Murphy; Cyndi J Tifft; Eliza Gordon-Lipkin
Journal:  Mol Genet Genomic Med       Date:  2021-05-07       Impact factor: 2.183

9.  Sequence variation in human succinate dehydrogenase genes: evidence for long-term balancing selection on SDHA.

Authors:  Bora E Baysal; Elizabeth C Lawrence; Robert E Ferrell
Journal:  BMC Biol       Date:  2007-03-21       Impact factor: 7.431

10.  Individual-specific variation in the respiratory activities of HMECs and their bioenergetic response to IGF1 and TNFα.

Authors:  Sallie S Schneider; Elizabeth M Henchey; Nazneen Sultana; Stephanie M Morin; D Joseph Jerry; Grace Makari-Judson; Giovanna M Crisi; Richard B Arenas; Melissa Johnson; Holly S Mason; Nagendra Yadava
Journal:  J Cell Physiol       Date:  2017-05-15       Impact factor: 6.384

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.